Clinical Trial Update: Rectal Indomethacin to Prevent Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis [Phase 3]

View source ↗

Summary

A Phase 3 trial tested whether rectal indomethacin can prevent pancreatitis after ERCP. The study was terminated, and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis
• Post-ercp Pancreatitis

Drugs mentioned

• Rectal Indomethacin (indomethacin)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Post-ERCP Acute Pancreatitis | Phase 3 | Status: TERMINATED | Results posted: 2016-09-20